Sotirakis, C., Brzezicki, M. A., Patel, S., Conway, N., FitzGerald, J. J., & Antoniades, C. A. (2024) Predicting future fallers in Parkinson’s Disease using kinematic data over a period of 5 years. https://doi.org/10.1038/s41746-024-01311-5
Gibbs, M. C., Huxley, J., Readman, M., Polden, M., Bredemeyer, O., Crawford, T. J., & Antoniades, C. A. (2024). Naturalistic Eye Movement Tasks in Parkinson’s Disease: A Systematic Review. https://doi.org/10.3233/JPD-240092
Patel, S., Goh, V., FitzGerald, J. J., & Antoniades, C.A. (2024). 2D and 3D Deep Learning Models for MRI-based Parkinson’s Disease Classification: A Comprehensive Analysis of Convolutional Kolmogorov-Arnold Networks, Convolutional Neural Networks, and Graph Convolutional Networks. https://doi.org/10.48550/arXiv.2407.17380
Patel, S., Bredemeyer, O., FitzGerald, J. J., & Antoniades, C. A. (2024). Hierarchical Machine Learning Classification of Parkinsonian Disorders using Saccadic Eye Movements: A Development and Validation Study. https://arxiv.org/abs/2407.16063
Sotirakis, C., Su, Z., Brzezicki, M. A., Conway, N., Tarassenko, L., FitzGerald, J. J., & Antoniades, C. A. (2023). Identification of motor progression in Parkinson’s disease using wearable sensors and machine learning. Npj Parkinson’s Disease, 9(1), 1–8. https://doi.org/10.1038/s41531-023-00581-2
Brzezicki, M. A., Conway, N., Sotirakis, C., FitzGerald, J. J., & Antoniades, C. A. (2023). Antiparkinsonian medication masks motor signal progression in de novo patients. Heliyon, 9(6). https://doi.org/10.1016/j.heliyon.2023.e16415
Bredemeyer, O., Patel, S., FitzGerald, J. J., & Antoniades, C. A. (2022). Oculomotor deficits in Parkinson’s disease: Increasing sensitivity using multivariate approaches. Frontiers in Digital Health, 4. https://doi.org/10.3389/fdgth.2022.939677
Su, Z. H., Patel, S., Bredemeyer, O., FitzGerald, J. J., & Antoniades, C. A. (2022). Parkinson’s disease deficits in time perception to auditory as well as visual stimuli – A large online study. Frontiers in Neuroscience, 16. https://doi.org/10.3389/fnins.2022.995438
Sotirakis, C., Conway, N., Su, Z., Villarroel, M., Tarassenko, L., FitzGerald, J. J., & Antoniades, C. A. (2022). Longitudinal Monitoring of Progressive Supranuclear Palsy using Body-Worn Movement Sensors. Movement Disorders, 37(11), 2263–2271. https://doi.org/10.1002/mds.29194
Pereira, M. F., Buchanan, T., Höglinger, G. U., Bogdanovic, M., Tofaris, G., Prangnell, S., Sarangmat, N., FitzGerald, J. J., & Antoniades, C. A. (2022). Longitudinal changes of early motor and cognitive symptoms in progressive supranuclear palsy: The OxQUIP study. BMJ Neurology Open, 4(1), e000214. https://doi.org/10.1136/bmjno-2021-000214
Brzezicki, M. A., Bogdanovic, M., Buchanan, T., FitzGerald, J. J., & Antoniades, C. A. (2021). Strategy Adherence: A Specific and Rapidly Progressive Deficit in Progressive Supranuclear Palsy. Movement Disorders Clinical Practice, 8(8), 1272–1274. https://doi.org/10.1002/mdc3.13334
De Vos, M., Prince, J., Buchanan, T., FitzGerald, J. J., & Antoniades, C. A. (2020). Discriminating progressive supranuclear palsy from Parkinson’s disease using wearable technology and machine learning. Gait & Posture, 77, 257–263. https://doi.org/10.1016/j.gaitpost.2020.02.007
Lu, Z., Buchanan, T., Kennard, C., FitzGerald, J. J., & Antoniades, C. A. (2019). The effect of levodopa on saccades – Oxford Quantification in Parkinsonism study. Parkinsonism & Related Disorders, 68, 49–56. https://doi.org/10.1016/j.parkreldis.2019.09.029
FitzGerald, J. J., Lu, Z., Jareonsettasin, P., & Antoniades, C. A. (2018). Quantifying Motor Impairment in Movement Disorders. Frontiers in Neuroscience, 12. https://doi.org/10.3389/fnins.2018.00202
FitzGerald, J. J., & Antoniades, C. A. (2016). Eye movements and deep brain stimulation. Current Opinion in Neurology, 29(1), 69. https://doi.org/10.1097/WCO.0000000000000276